Runcaciguat (Synonyms: BAY 1101042) |
| Katalog-Nr.GC65192 |
Runcaciguat ist ein oral aktiver Stimulator der lÖslichen Guanylatcyclase und wird in der Erforschung von Herz-Kreislauf- und Nierenerkrankungen in Kombination mit selektiven partiellen Adenosin-A1-Rezeptor-Agonisten eingesetzt.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1402936-61-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Runcaciguat is an orally active stimulator of soluble guanylate cyclase, and is used in the research of cardiovascular and renal diseases combined with selective partial adenosine A1 receptor agonists[1].
[1]. Barbara ALBRECHT-KÜPPER, et al. Selective partial adenosine a1 receptor agonists in combination with soluble guanylyl cyclase (sgc) stimulators and/or activators. WO2018153899A1.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *